Molecular mechanisms and binding site locations for noncompetitive antagonists of nicotinic acetylcholine receptors

Hugo R. Arias, Pankaj Bhumireddy, Cecilia Bouzat

Research output: Contribution to journalReview article

110 Citations (Scopus)

Abstract

Nicotinic acetylcholine receptors are pentameric proteins that belong to the Cys-loop receptor superfamily. Their essential mechanism of functioning is to couple neurotransmitter binding, which occurs at the extracellular domain, to the opening of the membrane-spanning cation channel. The function of these receptors can be modulated by structurally different compounds called noncompetitive antagonists. Noncompetitive antagonists may act at least by two different mechanisms: a steric and/or an allosteric mechanism. The simplest idea representing a steric mechanism is that the antagonist molecule physically blocks the ion channel. On the other hand, there exist distinct allosteric mechanisms. For example, noncompetitive antagonists may bind to the receptor and stabilize a nonconducting conformational state (e.g., resting or desensitized state), and/or increase the receptor desensitization rate. Barbiturates, dissociative anesthetics, antidepressants, and neurosteroids have been shown to inhibit nicotinic receptors by allosteric mechanisms and/or by open- and closed-channel blockade. Receptor modulation has proved to be highly complex for most noncompetitive antagonists. Noncompetitive antagonists may act by more than one mechanism and at distinct sites in the same receptor subtype. The binding site location for one particular molecule depends on the conformational state of the receptor. The mechanisms of action and binding affinities of noncompetitive antagonists differ among nicotinic receptor subtypes. Knowledge of the structure of the nicotinic acetylcholine receptor, the location of its noncompetitive antagonist binding sites, and the mechanisms of inhibition will aid the design of new and more efficacious drugs for treatment of neurological diseases.

Original languageEnglish
Pages (from-to)1254-1276
Number of pages23
JournalInternational Journal of Biochemistry and Cell Biology
Volume38
Issue number8
DOIs
StatePublished - 8 May 2006
Externally publishedYes

Fingerprint

Nicotinic Receptors
Binding Sites
Neurotransmitter Agents
Cysteine Loop Ligand-Gated Ion Channel Receptors
Dissociative Anesthetics
Barbiturates
Molecules
Ion Channels
Antidepressive Agents
Cations
Modulation
Membranes
Pharmaceutical Preparations
Proteins

Keywords

  • Nicotinic acetylcholine receptors
  • Noncompetitive inhibitors

Cite this

@article{f0fe326422bb4100a8f974a6268fbed6,
title = "Molecular mechanisms and binding site locations for noncompetitive antagonists of nicotinic acetylcholine receptors",
abstract = "Nicotinic acetylcholine receptors are pentameric proteins that belong to the Cys-loop receptor superfamily. Their essential mechanism of functioning is to couple neurotransmitter binding, which occurs at the extracellular domain, to the opening of the membrane-spanning cation channel. The function of these receptors can be modulated by structurally different compounds called noncompetitive antagonists. Noncompetitive antagonists may act at least by two different mechanisms: a steric and/or an allosteric mechanism. The simplest idea representing a steric mechanism is that the antagonist molecule physically blocks the ion channel. On the other hand, there exist distinct allosteric mechanisms. For example, noncompetitive antagonists may bind to the receptor and stabilize a nonconducting conformational state (e.g., resting or desensitized state), and/or increase the receptor desensitization rate. Barbiturates, dissociative anesthetics, antidepressants, and neurosteroids have been shown to inhibit nicotinic receptors by allosteric mechanisms and/or by open- and closed-channel blockade. Receptor modulation has proved to be highly complex for most noncompetitive antagonists. Noncompetitive antagonists may act by more than one mechanism and at distinct sites in the same receptor subtype. The binding site location for one particular molecule depends on the conformational state of the receptor. The mechanisms of action and binding affinities of noncompetitive antagonists differ among nicotinic receptor subtypes. Knowledge of the structure of the nicotinic acetylcholine receptor, the location of its noncompetitive antagonist binding sites, and the mechanisms of inhibition will aid the design of new and more efficacious drugs for treatment of neurological diseases.",
keywords = "Nicotinic acetylcholine receptors, Noncompetitive inhibitors",
author = "Arias, {Hugo R.} and Pankaj Bhumireddy and Cecilia Bouzat",
year = "2006",
month = "5",
day = "8",
doi = "10.1016/j.biocel.2006.01.006",
language = "English",
volume = "38",
pages = "1254--1276",
journal = "International Journal of Biochemistry and Cell Biology",
issn = "1357-2725",
number = "8",

}

Molecular mechanisms and binding site locations for noncompetitive antagonists of nicotinic acetylcholine receptors. / Arias, Hugo R.; Bhumireddy, Pankaj; Bouzat, Cecilia.

In: International Journal of Biochemistry and Cell Biology, Vol. 38, No. 8, 08.05.2006, p. 1254-1276.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Molecular mechanisms and binding site locations for noncompetitive antagonists of nicotinic acetylcholine receptors

AU - Arias, Hugo R.

AU - Bhumireddy, Pankaj

AU - Bouzat, Cecilia

PY - 2006/5/8

Y1 - 2006/5/8

N2 - Nicotinic acetylcholine receptors are pentameric proteins that belong to the Cys-loop receptor superfamily. Their essential mechanism of functioning is to couple neurotransmitter binding, which occurs at the extracellular domain, to the opening of the membrane-spanning cation channel. The function of these receptors can be modulated by structurally different compounds called noncompetitive antagonists. Noncompetitive antagonists may act at least by two different mechanisms: a steric and/or an allosteric mechanism. The simplest idea representing a steric mechanism is that the antagonist molecule physically blocks the ion channel. On the other hand, there exist distinct allosteric mechanisms. For example, noncompetitive antagonists may bind to the receptor and stabilize a nonconducting conformational state (e.g., resting or desensitized state), and/or increase the receptor desensitization rate. Barbiturates, dissociative anesthetics, antidepressants, and neurosteroids have been shown to inhibit nicotinic receptors by allosteric mechanisms and/or by open- and closed-channel blockade. Receptor modulation has proved to be highly complex for most noncompetitive antagonists. Noncompetitive antagonists may act by more than one mechanism and at distinct sites in the same receptor subtype. The binding site location for one particular molecule depends on the conformational state of the receptor. The mechanisms of action and binding affinities of noncompetitive antagonists differ among nicotinic receptor subtypes. Knowledge of the structure of the nicotinic acetylcholine receptor, the location of its noncompetitive antagonist binding sites, and the mechanisms of inhibition will aid the design of new and more efficacious drugs for treatment of neurological diseases.

AB - Nicotinic acetylcholine receptors are pentameric proteins that belong to the Cys-loop receptor superfamily. Their essential mechanism of functioning is to couple neurotransmitter binding, which occurs at the extracellular domain, to the opening of the membrane-spanning cation channel. The function of these receptors can be modulated by structurally different compounds called noncompetitive antagonists. Noncompetitive antagonists may act at least by two different mechanisms: a steric and/or an allosteric mechanism. The simplest idea representing a steric mechanism is that the antagonist molecule physically blocks the ion channel. On the other hand, there exist distinct allosteric mechanisms. For example, noncompetitive antagonists may bind to the receptor and stabilize a nonconducting conformational state (e.g., resting or desensitized state), and/or increase the receptor desensitization rate. Barbiturates, dissociative anesthetics, antidepressants, and neurosteroids have been shown to inhibit nicotinic receptors by allosteric mechanisms and/or by open- and closed-channel blockade. Receptor modulation has proved to be highly complex for most noncompetitive antagonists. Noncompetitive antagonists may act by more than one mechanism and at distinct sites in the same receptor subtype. The binding site location for one particular molecule depends on the conformational state of the receptor. The mechanisms of action and binding affinities of noncompetitive antagonists differ among nicotinic receptor subtypes. Knowledge of the structure of the nicotinic acetylcholine receptor, the location of its noncompetitive antagonist binding sites, and the mechanisms of inhibition will aid the design of new and more efficacious drugs for treatment of neurological diseases.

KW - Nicotinic acetylcholine receptors

KW - Noncompetitive inhibitors

UR - http://www.scopus.com/inward/record.url?scp=33646177253&partnerID=8YFLogxK

U2 - 10.1016/j.biocel.2006.01.006

DO - 10.1016/j.biocel.2006.01.006

M3 - Review article

C2 - 16520081

AN - SCOPUS:33646177253

VL - 38

SP - 1254

EP - 1276

JO - International Journal of Biochemistry and Cell Biology

JF - International Journal of Biochemistry and Cell Biology

SN - 1357-2725

IS - 8

ER -